1.           Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1         US and Europe Cell and Gene Therapy Manufacturing Services Market – by Type

1.3.2         US and Europe Cell and Gene Therapy Manufacturing Services Market – by Indication

1.3.3         US and Europe Cell and Gene Therapy Manufacturing Services Market – by Application

1.3.4         US and Europe Cell and Gene Therapy Manufacturing Services Market – by End User

1.3.5         US and Europe Cell and Gene Therapy Manufacturing Services Market – by Country & Region

2.           US and Europe Cell and Gene Therapy Manufacturing Services Market – Key Takeaways

3.       Research Methodology

3.2       Coverage

3.3       Secondary Research

3.4       Primary Research

4.           US and Europe Cell and Gene Therapy Manufacturing Services Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1         US PEST Analysis

4.2.2         Europe PEST Analysis

4.3       Expert’s Opinion

5.           US and Europe Cell and Gene Therapy Manufacturing Services Market – Key Market Dynamics

5.1       Market Drivers

5.1.1         Increase in Number of Approval of Cell and Gene Therapies

5.1.2         Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing

5.2       Market Restraints

5.2.1         High Cost of Cell and Gene Therapy Manufacturing

5.3       Market Opportunities

5.3.1         Strategic Initiatives by Companies

5.4       Future Trends

5.4.1         Automation of Cell and Gene Therapy Manufacturing Services

5.5       Impact Analysis

6.           US and Europe Cell and Gene Therapy Manufacturing Services Market – Country & Regional Analysis

6.1       US and Europe Cell and Gene Therapy Manufacturing Services Market Revenue Forecast and Analysis

6.2       Market Positioning of Key Players

7.           US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 – by Type

7.1       Overview

7.2       US and Europe Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Type 2022 & 2030 (%)

7.3       Cell Therapy

7.3.1         Overview

7.3.2         Cell Therapy: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

7.3.2.1            Autologous

7.3.2.1.1           Overview

7.3.2.1.2           Autologous: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

7.3.2.2            Allogenic

7.3.2.2.1           Overview

7.3.2.2.2           Allogenic: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

7.4       Gene Therapy

7.4.1         Overview

7.4.2         Gene Therapy: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

7.4.2.1            Viral Vector

7.4.2.1.1           Overview

7.4.2.1.2           Viral Vector: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

7.4.2.2            Non-Viral Vector

7.4.2.2.1           Overview

7.4.2.2.2           Non-Viral Vector: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

8.           US and Europe Cell and Gene Therapy Manufacturing Services Market Analysis and Forecasts to 2030 – by Indication

8.1       Overview

8.2       US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication 2022 & 2030 (%)

8.3       Cancer

8.3.1         Overview

8.3.2         Cancer: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

8.4       Orthopedics

8.4.1         Overview

8.4.2         Orthopedics: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

8.5       Others

8.5.1         Overview

8.5.2         Others: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

9.           US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 – by Application

9.1       Overview

9.2       US and Europe Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Application 2022 & 2030 (%)

9.4       Clinical Manufacturing

9.4.1         Overview

9.4.2         Clinical Manufacturing: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

9.5       Commercial Manufacturing

9.5.1         Overview

9.5.2         Commercial Manufacturing: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

10.        US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 – by End User

10.1     Overview

10.2     US and Europe Cell and Gene Therapy Manufacturing Services Market Revenue Share, by End User 2022 & 2030 (%)

10.4     Pharmaceutical and Biotechnology Companies

10.4.1       Overview

10.4.2       Pharmaceutical & Biotechnology Companies: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

10.5     Contract Research Organizations (CROs)

10.5.1       Overview

10.5.2       Contract Research Organizations (CROs): US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.        US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 – Country & Regional Analysis

11.1     US: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1       Overview

11.1.2       US: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.1.2.1          US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)

11.1.2.1.1        US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)

11.1.2.1.2        US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)

11.1.2.2          US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)

11.1.2.3          US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)

11.1.2.4          US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)

11.2     Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market

11.2.1       Overview

11.2.2       Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.3       Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)

11.2.3.1          Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)

11.2.3.2          Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)

11.2.4       Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)

11.2.5       Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)

11.2.6       Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)

11.2.7       Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Country, 2022 & 2030 (%)

11.2.7.1          Germany: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.7.1.1        Overview

11.2.7.1.2        Germany: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.7.1.3        Germany: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)

11.2.7.1.3.1        Germany: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)

11.2.7.1.3.2        Germany: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)

11.2.7.1.4        Germany: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)

11.2.7.1.5        Germany: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)

11.2.7.1.6        Germany: US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)

11.2.7.2          UK: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.7.2.1        Overview

11.2.7.2.2        UK: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.7.2.3        UK: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)

11.2.7.2.3.1        UK: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)

11.2.7.2.3.2        UK: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)

11.2.7.2.4        UK: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)

11.2.7.2.5        UK: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)

11.2.7.2.6        UK: US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)

11.2.7.3          France: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.7.3.1        Overview

11.2.7.3.2        France: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.7.3.3        France: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)

11.2.7.3.3.1        France: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)

11.2.7.3.3.2        France: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)

11.2.7.3.4        France: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)

11.2.7.3.5        France: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)

11.2.7.3.6        France: US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)

11.2.7.4          Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.7.4.1        Overview

11.2.7.4.2        Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.7.4.3        Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)

11.2.7.4.3.1        Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)

11.2.7.4.3.2        Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)

11.2.7.4.4        Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)

11.2.7.4.5        Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)

11.2.7.4.6        Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)

11.2.7.5          Spain: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.7.5.1        Overview

11.2.7.5.2        Spain: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.7.5.3        Spain: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)

11.2.7.5.3.1        Spain: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)

11.2.7.5.3.2        Spain: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)

11.2.7.5.4        Spain: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)

11.2.7.5.5        Spain: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)

11.2.7.5.6        Spain: US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)

11.2.7.6          Rest of Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.7.6.1        Overview

11.2.7.6.2        Rest of Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.7.6.3        Rest of Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)

11.2.7.6.3.1        Rest of Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)

11.2.7.6.3.2        Rest of Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)

11.2.7.6.4        Rest of Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)

11.2.7.6.5        Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)

11.2.7.6.6        Rest of Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)

12.        US and Europe Cell and Gene Therapy Manufacturing Services Market – Industry Landscape

12.1     Overview

12.2     Growth Strategies in US and Europe Cell and Gene Therapy Manufacturing Services Market

12.3     Organic Growth Strategies

12.3.1       Overview

12.4     Inorganic Growth Strategies

12.4.1       Overview

13.        Company Profiles

13.1     Thermo Fisher Scientific Inc

13.1.1       Key Facts

13.1.2       Business Description

13.1.3       Products and Services

13.1.4       Financial Overview

13.1.5       SWOT Analysis

13.1.6       Key Developments

13.2     Merck KGaA

13.2.1       Key Facts

13.2.2       Business Description

13.2.3       Products and Services

13.2.4       Financial Overview

13.2.5       SWOT Analysis

13.2.6       Key Developments

13.3     Charles River Laboratories International Inc

13.3.1       Key Facts

13.3.2       Business Description

13.3.3       Products and Services

13.3.4       Financial Overview

13.3.5       SWOT Analysis

13.3.6       Key Developments

13.4     Lonza Group AG

13.4.1       Key Facts

13.4.2       Business Description

13.4.3       Products and Services

13.4.4       Financial Overview

13.4.5       SWOT Analysis

13.4.6       Key Developments

13.5     WuXi AppTec Co Ltd

13.5.1       Key Facts

13.5.2       Business Description

13.5.3       Products and Services

13.5.4       Financial Overview

13.5.5       SWOT Analysis

13.5.6       Key Developments

13.6     Catalent Inc

13.6.1       Key Facts

13.6.2       Business Description

13.6.3       Products and Services

13.6.4       Financial Overview

13.6.5       SWOT Analysis

13.6.6       Key Developments

13.7     Takara Bio Inc

13.7.1       Key Facts

13.7.2       Business Description

13.7.3       Products and Services

13.7.4       Financial Overview

13.7.5       SWOT Analysis

13.7.6       Key Developments

13.8     Nikon Corp

13.8.1       Key Facts

13.8.2       Business Description

13.8.3       Products and Services

13.8.4       Financial Overview

13.8.5       SWOT Analysis

13.8.6       Key Developments

13.9     FUJIFILM Holdings Corp

13.9.1       Key Facts

13.9.2       Business Description

13.9.3       Products and Services

13.9.4       Financial Overview

13.9.5       SWOT Analysis

13.9.6       Key Developments

13.10  National Resilience Inc

13.10.1    Key Facts

13.10.2    Business Description

13.10.3    Products and Services

13.10.4    Financial Overview

13.10.5    SWOT Analysis

13.10.6    Key Developments

13.11  Oxford BioMedica Plc

13.11.1    Key Facts

13.11.2    Business Description

13.11.3    Products and Services

13.11.4    Financial Overview

13.11.5    SWOT Analysis

13.11.6    Key Developments

14.        Appendix

14.1     About The Insight Partners

14.2     Glossary of Terms

LIST OF TABLES

Table 1.             US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type – Revenue and Forecast to 2030 (US$ Million)

Table 2.             US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy – Revenue and Forecast to 2030 (US$ Million)

Table 3.             US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy – Revenue and Forecast to 2030 (US$ Million)

Table 4.             US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication – Revenue and Forecast to 2030 (US$ Million)

Table 5.             US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 6.             US: US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 7.             Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type – Revenue and Forecast to 2030 (US$ Million)

Table 8.             Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy – Revenue and Forecast to 2030 (US$ Million)

Table 9.             Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy – Revenue and Forecast to 2030 (US$ Million)

Table 10.          Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication – Revenue and Forecast to 2030 (US$ Million)

Table 11.          Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 12.          Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 13.          Germany US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type – Revenue and Forecast to 2030 (US$ Million)

Table 14.          Germany US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy – Revenue and Forecast to 2030 (US$ Million)

Table 15.          Germany US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy – Revenue and Forecast to 2030 (US$ Million)

Table 16.          Germany US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication – Revenue and Forecast to 2030 (US$ Million)

Table 17.          Germany US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 18.          Germany US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 19.          UK US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type – Revenue and Forecast to 2030 (US$ Million)

Table 20.          UK US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy – Revenue and Forecast to 2030 (US$ Million)

Table 21.          UK US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy – Revenue and Forecast to 2030 (US$ Million)

Table 22.          UK US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication – Revenue and Forecast to 2030 (US$ Million)

Table 23.          UK US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 24.          UK US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 25.          France US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type – Revenue and Forecast to 2030 (US$ Million)

Table 26.          France US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy – Revenue and Forecast to 2030 (US$ Million)

Table 27.          France US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy – Revenue and Forecast to 2030 (US$ Million)

Table 28.          France US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication – Revenue and Forecast to 2030 (US$ Million)

Table 29.          France US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 30.          France US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 31.          Italy US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type – Revenue and Forecast to 2030 (US$ Million)

Table 32.          Italy US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy – Revenue and Forecast to 2030 (US$ Million)

Table 33.          Italy US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy – Revenue and Forecast to 2030 (US$ Million)

Table 34.          Italy US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication – Revenue and Forecast to 2030 (US$ Million)

Table 35.          Italy US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 36.          Italy US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 37.          Spain US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type – Revenue and Forecast to 2030 (US$ Million)

Table 38.          Spain US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy – Revenue and Forecast to 2030 (US$ Million)

Table 39.          Spain US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy – Revenue and Forecast to 2030 (US$ Million)

Table 40.          Spain US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication – Revenue and Forecast to 2030 (US$ Million)

Table 41.          Spain US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 42.          Spain US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 43.          Rest of Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by Type – Revenue and Forecast to 2030 (US$ Million)

Table 44.          Rest of Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy – Revenue and Forecast to 2030 (US$ Million)

Table 45.          Rest of Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy – Revenue and Forecast to 2030 (US$ Million)

Table 46.          Rest of Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by Indication – Revenue and Forecast to 2030 (US$ Million)

Table 47.          Italy US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 48.          Rest of Europe US and Europe Cell and Gene Therapy Manufacturing Services Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 49.          Recent Organic Growth Strategies in US and Europe Cell and Gene Therapy Manufacturing Services Market

Table 50.          Recent Inorganic Growth Strategies in the US and Europe Cell and Gene Therapy Manufacturing Services Market

Table 51.          Glossary of Terms

LIST OF FIGURES

Figure 1.           US and Europe Cell and Gene Therapy Manufacturing Services Market Segmentation

Figure 2.           US and Europe Cell and Gene Therapy Manufacturing Services Market, by Region

Figure 3.           US and Europe Cell and Gene Therapy Manufacturing Services Market Overview

Figure 4.           Cell Therapy Segment Held Largest Share of Type Segment in US and Europe Cell and Gene Therapy Manufacturing Services Market

Figure 5.           US and Europe Cell and Gene Therapy Manufacturing Services Market, by Country & Region (US$ Million)

Figure 6.           US and Europe Cell and Gene Therapy Manufacturing Services Market – Leading Country Markets (US$ Million)

Figure 7.           US and Europe Cell and Gene Therapy Manufacturing Services Market – Industry Landscape

Figure 8.           US: PEST Analysis

Figure 9.           Europe: PEST Analysis

Figure 10.        Experts’ Opinion

Figure 11.        US and Europe Cell and Gene Therapy Manufacturing Services Market: Key Industry Dynamics

Figure 12.        US and Europe Cell and Gene Therapy Manufacturing Services Market: Impact Analysis of Drivers and Restraints

Figure 13.        US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue Forecast and Analysis – 2021-2030

Figure 14.        Market Positioning of Key Players in US and Europe Cell and Gene Therapy Manufacturing Services Market

Figure 15.        US and Europe Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Type 2022 & 2030 (%)

Figure 16.        Cell Therapy: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 17.        Autologous: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 18.        Allogenic: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 19.        Gene Therapy: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 20.        Viral Vector: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21.        Non-Viral Vector: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 22.        US and Europe Cell and Gene Therapy Manufacturing Services Market, by Application 2022 & 2030 (%)

Figure 23.        Cancer: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 24.        Orthopedics: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 25.        Others: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 26.        US and Europe Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Application 2022 & 2030 (%)

Figure 27.        Clinical Manufacturing: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 28.        Commercial Manufacturing: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 29.        US and Europe Cell and Gene Therapy Manufacturing Services Market Revenue Share, by End User 2022 & 2030 (%)

Figure 30.        Pharmaceutical & Biotechnology Companies: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 31.        Contract Research Organizations (CROs): US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 32.        United States: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Key Country – Revenue (2022) (US$ Million)

Figure 33.        US: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 34.        Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Key Country – Revenue (2022) (US$ Million)

Figure 35.        Europe US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 36.        Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market, by Country, 2022 & 2030 (%)

Figure 37.        Germany: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 38.        UK: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 39.        France: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 40.        Italy: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 41.        Spain: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 42.        Rest of Europe: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

Figure 43.        Growth Strategies in US and Europe Cell and Gene Therapy Manufacturing Services Market